메뉴 건너뛰기




Volumn 18, Issue 2, 2011, Pages 131-137

Statin treatment decreased serum asymmetric dimethylarginine (ADMA) levels in Ischemic stroke patients

Author keywords

ADMA; Ischemic stroke; Pleiotropic effect; Statin

Indexed keywords

ACETYLSALICYLIC ACID; ATORVASTATIN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL; N(G),N(G) DIMETHYLARGININE; PITAVASTATIN; PRAVASTATIN;

EID: 79952395245     PISSN: 13403478     EISSN: 18803873     Source Type: Journal    
DOI: 10.5551/jat.5553     Document Type: Article
Times cited : (29)

References (30)
  • 2
    • 0037031061 scopus 로고    scopus 로고
    • MRC/BHF heart protection study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: A randomised placebo- controlled trial
    • Heart Protection Study Collaborative Group
    • Heart Protection Study Collaborative Group: MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo- controlled trial. Lancet, 2002; 360: 7-22
    • (2002) Lancet , vol.360 , pp. 7-22
  • 5
    • 0037420492 scopus 로고    scopus 로고
    • ASCOT investigators: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): A multicentre randomised controlled trial
    • Sever PS, Dahlöf B, Poulter NR, Wedel H, Beevers G, Caulfield M, Collins R, Kjeldsen SE, Kristinsson A, McInnes GT, Mehlsen J, Nieminen M, O'Brien E, Ostergren J; ASCOT investigators: Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial--Lipid Lowering Arm (ASCOT-LLA): a multicentre randomised controlled trial. Lancet, 2003; 361: 1149-1158
    • (2003) Lancet , vol.361 , pp. 1149-1158
    • Sever, P.S.1    Dahlöf, B.2    Poulter, N.R.3    Wedel, H.4    Beevers, G.5    Caulfield, M.6    Collins, R.7    Kjeldsen, S.E.8    Kristinsson, A.9    McInnes, G.T.10    Mehlsen, J.11    Nieminen, M.12    O'Brien, E.13    Ostergren, J.14
  • 6
    • 1542345696 scopus 로고    scopus 로고
    • Heart protection study collaborative group: Effects of cholesterol- lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions
    • Collins R, Armitage J, Parish S, Sleight P, Peto R. Heart Protection Study Collaborative Group: Effects of cholesterol- lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Lancet, 2004; 363: 757-767
    • (2004) Lancet , vol.363 , pp. 757-767
    • Collins, R.1    Armitage, J.2    Parish, S.3    Sleight, P.4    Peto, R.5
  • 7
    • 0034003042 scopus 로고    scopus 로고
    • Nitric oxide and vascular responses in Type I diabetes
    • Chan NN, Vallance P, Colhoun HM: Nitric oxide and vascular responses in Type I diabetes. Diabetologia, 2000; 43: 137-147
    • (2000) Diabetologia , vol.43 , pp. 137-147
    • Chan, N.N.1    Vallance, P.2    Colhoun, H.M.3
  • 15
    • 3142606890 scopus 로고    scopus 로고
    • Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia
    • Lu TM, Ding YA, Leu HB, Yin WH, Sheu WH, Chu KM: Effect of rosuvastatin on plasma levels of asymmetric dimethylarginine in patients with hypercholesterolemia. Am J Cardiol, 2004; 94: 157-161
    • (2004) Am J Cardiol , vol.94 , pp. 157-161
    • Lu, T.M.1    Ding, Y.A.2    Leu, H.B.3    Yin, W.H.4    Sheu, W.H.5    Chu, K.M.6
  • 17
    • 34548530600 scopus 로고    scopus 로고
    • Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats
    • Tanaka N, Katayama Y, Katsumata T, Otori T, Nishiyama Y: Effects of long-term administration of HMG-CoA reductase inhibitor, atorvastatin, on stroke events and local cerebral blood flow in stroke-prone spontaneously hypertensive rats. Brain Res, 2007; 1169: 125-132
    • (2007) Brain Res , vol.1169 , pp. 125-132
    • Tanaka, N.1    Katayama, Y.2    Katsumata, T.3    Otori, T.4    Nishiyama, Y.5
  • 20
    • 0033984125 scopus 로고    scopus 로고
    • The evolving role of statins in the management of atherosclerosis
    • Vaughan CJ, Gotto AM Jr, Basson CT: The evolving role of statins in the management of atherosclerosis. J Am Coll Cardiol, 2000; 35: 1-10
    • (2000) J Am Coll Cardiol , vol.35 , pp. 1-10
    • Vaughan, C.J.1    Gotto Jr., A.M.2    Basson, C.T.3
  • 21
    • 0034037024 scopus 로고    scopus 로고
    • Impaired endothelial function in arterial hypertension and hypercholesterolemia: Potential mechanisms and differences
    • John S, Schmieder RE: Impaired endothelial function in arterial hypertension and hypercholesterolemia: potential mechanisms and differences. J Hypertens, 2000; 18: 363-374
    • (2000) J Hypertens , vol.18 , pp. 363-374
    • John, S.1    Schmieder, R.E.2
  • 22
    • 0038796967 scopus 로고    scopus 로고
    • Heads and hearts. The endothelial connection
    • Vogel RA: Heads and hearts. The endothelial connection. Circulation, 2003; 107: 2766-2768
    • (2003) Circulation , vol.107 , pp. 2766-2768
    • Vogel, R.A.1
  • 23
    • 0034698038 scopus 로고    scopus 로고
    • LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: Involvement of S-adenosylmethionine- dependent methyltransferases
    • Böger RH, Sydow K, Borlak J, Thum T, Lenzen H, Schubert B, Tsikas D, Bode-Böger SM: LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylmethionine- dependent methyltransferases. Circ Res, 2000; 87: 99-105
    • (2000) Circ Res , vol.87 , pp. 99-105
    • Böger, R.H.1    Sydow, K.2    Borlak, J.3    Thum, T.4    Lenzen, H.5    Schubert, B.6    Tsikas, D.7    Bode-Böger, S.M.8
  • 24
    • 0242640310 scopus 로고    scopus 로고
    • Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease
    • Böger RH, Bode-Böger SM, Thiele W, Junker W, Alexander K, Flölich JC: Biochemical evidence for impaired nitric oxide synthesis in patients with peripheral arterial occlusive disease. Circulation, 1997; 95: 2068-2074
    • (1997) Circulation , vol.95 , pp. 2068-2074
    • Böger, R.H.1    Bode-Böger, S.M.2    Thiele, W.3    Junker, W.4    Alexander, K.5    Flölich, J.C.6
  • 27
    • 0034813226 scopus 로고    scopus 로고
    • Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke
    • Yoo JH, Lee SC: Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke. Atherosclerosis, 2001; 158: 425-430
    • (2001) Atherosclerosis , vol.158 , pp. 425-430
    • Yoo, J.H.1    Lee, S.C.2
  • 28
    • 0036900697 scopus 로고    scopus 로고
    • Statins and stroke: Evidence for cholesterol-independent effects
    • Di Napoli P, Taccardi AA, Oliver M, De Caterina R: Statins and stroke: evidence for cholesterol-independent effects. Eur Heart J, 2002; 23: 1908-1921
    • (2002) Eur Heart J , vol.23 , pp. 1908-1921
    • di Napoli, P.1    Taccardi, A.A.2    Oliver, M.3    de Caterina, R.4
  • 29
    • 0032555154 scopus 로고    scopus 로고
    • Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase
    • Endres M, Laufs U, Huang Z, Nakamura T, Huang P, Moskowitz MA, Liao JK: Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase. Proc Natl Acad Sci USA, 1998; 95: 8880-8885
    • (1998) Proc Natl Acad Sci USA , vol.95 , pp. 8880-8885
    • Endres, M.1    Laufs, U.2    Huang, Z.3    Nakamura, T.4    Huang, P.5    Moskowitz, M.A.6    Liao, J.K.7
  • 30
    • 0033800718 scopus 로고    scopus 로고
    • Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice
    • Laufs U, Gertz K, Huang P, Nickenig G, Böhm M, Dirnagl U, Endres M: Atorvastatin upregulates type III nitric oxide synthase in thrombocytes, decreases platelet activation, and protects from cerebral ischemia in normocholesterolemic mice. Stroke, 2000; 31: 2442-2449.
    • (2000) Stroke , vol.31 , pp. 2442-2449
    • Laufs, U.1    Gertz, K.2    Huang, P.3    Nickenig, G.4    Böhm, M.5    Dirnagl, U.6    Endres, M.7


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.